KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 88 filers reported holding KRONOS BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,900 | -72.8% | 23,000 | -64.0% | 0.00% | – |
Q2 2023 | $109,908 | -26.9% | 63,900 | -38.0% | 0.00% | – |
Q1 2023 | $150,380 | -36.4% | 103,000 | -29.4% | 0.00% | -100.0% |
Q4 2022 | $236,358 | -58.1% | 145,900 | -13.3% | 0.00% | -50.0% |
Q3 2022 | $564,000 | -7.8% | 168,244 | +0.0% | 0.00% | 0.0% |
Q2 2022 | $612,000 | -27.9% | 168,200 | +43.3% | 0.00% | 0.0% |
Q1 2022 | $849,000 | +24.5% | 117,400 | +133.9% | 0.00% | +100.0% |
Q4 2021 | $682,000 | -35.2% | 50,200 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $1,052,000 | -10.4% | 50,200 | +2.4% | 0.00% | 0.0% |
Q2 2021 | $1,174,000 | – | 49,006 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |